解读基因抑制β-glucuronidase的分子机制,由来自Centaurium spicatum的xanthon进行抑制
Emadeldin M Kamel1, Haifa A Alqhtani2, May Bin-Jumah2
1Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef 62514, Egypt.
Bioorganic chemistry
|July 4, 2024
概括
来自Centaurium spicatum的桑,特别是甘地和阿扎莱,显示出对β-glucuronidase的强烈抑制. 分子动力学模拟证实了稳定的药物酶相互作用,突出了复杂稳定中的范德瓦尔斯力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- β-glucuronidase是一种关键酶,涉及各种生理和病理过程.
- 天然产品,如香和黄类,正在研究它们的治疗潜力.
- 仙人掌 (Centaurium spicatum) 是生物活性化合物的植物来源.
研究的目的:
- 为了研究克桑和来自Centaurium spicatum的一种黄对β-glucuronidase的抑制作用.
- 用计算方法阐明这些化合物与β-葡萄糖酶的抑制机制和结合相互作用.
主要方法:
- 在体外酶抑制试验测试以确定IC50值.
- 酶动力学研究以确定抑制模式.
- 分子对接和分子动力学 (MD) 模拟来分析药物酶相互作用和结合部位占用.
主要成果:
- 甘提辛和阿扎莱丁表现出低IC50值的β-葡萄糖酶的强烈抑制.
- 克桑显示混合抑制,而阿扎莱显示非竞争性抑制.
- 分子对接和MD模拟揭示了稳定的药物酶复合体,其中阿扎莱显示出强烈的结合亲和力和范德瓦尔斯相互作用发挥着关键作用.
结论:
- 甘提辛和阿扎莱是β-glucuronidase的有前途的天然抑制剂.
- 这项研究提供了关于这些植物衍生化合物抑制β-葡萄糖酶的分子机制的见解.
- 这些研究结果支持在涉及β-glucuronidase活性的条件下这些ksanthones的潜在治疗应用.
相关概念视频
01:24Phase II Reactions: Glucuronidation
373
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
373
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
169
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
169
01:23Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
01:14Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K